SurvivorNet may be best known for its work in cancer but is now broadening its horizons into chronic conditions with a new focus on psoriasis.
The patient engagement media group is launching what it describes in a press release as a “comprehensive new destination” on psoriasis as it looks to “expand its content initiatives outside cancer” and into what it sees as “key chronic diseases” where “useful and inspiring patient-facing resources are lacking.”
To help with this, the organization has set up a new special resource section on psoriasis, offering up guidance from leading doctors in the field through short videos.
Its SurvivorNet TV, which has over the past two years been streaming content specifically for cancer, is now branching out into chronic diseases. SurvivorNet TV launched a new block of video programming to highlight “the kind of optimism, determination and strength that people living with psoriasis draw on to live their best lives,” according to the release.
The videos are focused on helping patients who are scared, discomfited and seeking the latest guidance on this difficult condition, the press release noted, given that psoriasis can lead to stigma and mental health issues as a result.
There are no direct, branded drug promotions as part of the website campaign, although the main psoriasis landing page on SurvivorNet does list biologics approved for the condition, including AbbVie’s blockbuster Humira—which made $20 billion last year and has a host of other FDA-approved uses—and Johnson & Johnson’s Tremfya, one of the newer drugs to treat the skin condition.
The organization is also showcasing patient stories about people living with psoriasis who've overcome its effects “with spirit and courage,” SurvivorNet said in its release, as well as with “the best available medical treatment,” which will include drugs.
The SurvivorNet TV streaming channels do, however, contain pharma drug ads, with its most recent videos promoting Bristol Myers Squibb’s checkpoint inhibitor drugs Yervoy and Opdivo. There were no psoriasis drug ads on the new videos for this latest campaign, though.